Skip to content

Auricular acupuncture combined with percutaneous auricular electrical stimulation for anxiety and depression in postoperative patients with breast cancer: assessor-participant blinded

Auricular acupuncture combined with percutaneous auricular electrical stimulation for anxiety and depression in postoperative patients with breast cancer: assessor-participant blinded

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081001
Enrollment
Unknown
Registered
2024-02-20
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and depression in postoperative patients with breast cancer

Interventions

Experimental group:Auricular acupuncture combined with percutaneous auricular electrical stimulation+ Psychological intervention

Sponsors

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Female, aged = 40 years and = 70 years; (2) Postoperative patients and histopathologically diagnosed as breast cancer, according to the Chinese society of clinical oncology breast cancer (CSCOBC) diagnosis and treatment guidelines (2023 version); (3) The score of Hospital anxiety and depression scale (HADS) was =8 and <15; (4) TCM syndrome differentiation as "Liver stagnation" (5) According to the Eastern Cooperative Oncology Group (ECoG) activity status score table, patients with a score of 0 or 1 ("0" stands for completely normal activity ability, without any difference from the activity ability before the onset; "1" stands for free walking and engaging in light physical activities, including general household or office work, but can not engage in heavy physical activities), their survival is predicted to be = 3 months; (6)No history of psychiatric illness in the past, and no psychotropic drugs such as antidepressant and anxiolytic drugs have been taken before entering this study (7) Follow the principle of voluntariness, and sign the informed consent before entering the study.

Exclusion criteria

Exclusion criteria: (1) Patients who are currently receiving surgery or who have surgery plans during the protocol; (2) Patients with severe heart, liver and kidney function injury, respiratory, blood and mental system or combined with other tumor diseases; (3) People who are not suitable for acupuncture treatment, such as: ear trauma, metal implantation higher than the neck level, serious skin disease, allergic constitution; (4)Diagnosis of organic psychiatric disorder and comorbid with other psychiatric disorders, or severe anxiety and depression persistent episodes, who requires psychiatric consultation; (5) Recent encounters with painful life events (e.g., divorce, widowhood, etc.) or traumatic events (e.g., natural disasters, man-made disasters, etc.) (6) Participated in other clinical research topics in the last 3 months.

Design outcomes

Primary

MeasureTime frame
Hospital anxiety and depression scale, HADS;

Secondary

MeasureTime frame
Hamilton Depression Scale, HAMD;Hamilton Anxiety Scale, HAMA;Pittsburgh Sleep Quality Index (PSQI);Heart rate variability (HRV);Functional Assessment of Cancer Therapy (FACT);Survival follow-up;Dosage taken during the study period;

Countries

China

Contacts

Public ContactJi Yajie

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

2373602874@qq.com+86 133 0177 9329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026